Family history and prostate cancer risk

American Journal of Epidemiology
S M LeskoS Shapiro

Abstract

The authors examined the relation between family history of prostate cancer and the risk of this cancer in a population-based case-control study conducted in Massachusetts between December 1992 and October 1994. Cases were all incident cases of prostate cancer in men younger than 70 years (n = 563); controls were men with no history of the disease matched to the cases on age and town of residence (n = 703). Prostate cancer risk was increased among men who reported a history of this cancer in either their fathers or brothers (odds ratio (OR) = 2.3, 95% confidence interval (CI) 1.7-3.3). Risk varied with the number of relatives affected and their relationship to the case. For a history of prostate cancer in one relative, the OR was 2.2 (95% CI 1.5-3.2); if two or more relatives were affected, it was 3.9 (95% CI 1.7-5.2). For prostate cancer in the father, the OR was 1.9 (95% CI 1.2-3.0); for prostate cancer in a brother, it was 3.0 (95% CI 1.8-4.9). Risk was inversely related to the subject's age and to age at diagnosis of prostate cancer in his affected relative. Among probands younger than 60 years, the OR was 5.3 (95% CI 2.5-12); for those 60-64 years of age, the OR was 2.7 (95% CI 1.3-5.5); and for those 65 years of age and o...Continue Reading

Citations

Sep 1, 2012·Journal of Immigrant and Minority Health·Barbara NemesureM Cristina Leske
Jun 6, 2009·Medical Oncology·Jing ZhangYun-Song Zhang
Jun 1, 2005·European Urology·Stéphane MallickLuc Multigner
Feb 13, 2001·Mutation Research·K Hemminki, P Mutanen
Nov 9, 2000·Urology·L A KalishJ B McKinlay
Feb 16, 1999·Biochimica Et Biophysica Acta·S Narod
Feb 25, 1999·International Journal of Radiation Oncology, Biology, Physics·M C HanusA Pollack
Mar 31, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K Hemminki, C Dong
Jun 11, 2009·Journal of Exposure Science & Environmental Epidemiology·Kristan J AronsonAlvara Morales
Feb 21, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Wael A Sakr
Jul 25, 2003·The New England Journal of Medicine·William G NelsonWilliam B Isaacs
May 29, 2009·Carcinogenesis·Jovanny ZabaletaAugusto C Ochoa
Jul 18, 2006·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Harvey J MurffWei Zheng
Dec 14, 2011·The Cancer Journal·Mark M Pomerantz, Matthew L Freedman
Mar 7, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S C KimR E Buller
Mar 25, 2006·BMC Public Health·Justine LeavyLin Fritschi
Jan 1, 2004·Hereditary Cancer in Clinical Practice·Sashi KommuRosalind Eeles
Jul 3, 2013·Asian Journal of Andrology·Aung Ko Win
Feb 4, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yu LuShan Li
Aug 17, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·O BrattH Olsson
Jul 12, 2011·Urologic Oncology·Felicity LoseUNKNOWN Australian Prostate Cancer BioResource
Jan 8, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Yan-Feng ZouFen Huang
Aug 12, 2008·International Journal of Radiation Oncology, Biology, Physics·Christopher A PetersNelson N Stone
Apr 3, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Paras B SinghFrancis L Martin
Jun 5, 2003·BJU International·L E Johns, R S Houlston
Apr 16, 2003·Clinical Genetics·A M NiederH Ostrer
Nov 26, 2010·The Mount Sinai Journal of Medicine, New York·Mark M Pomerantz, Matthew L Freedman
Sep 29, 2004·American Journal of Preventive Medicine·Harvey J MurffSapna Syngal
Dec 19, 2003·The Urologic Clinics of North America·Kisseng Hsieh, Peter C Albertsen
Mar 17, 2004·La Revue du praticien·Xavier RébillardArnauld Villers
Apr 20, 2001·American Journal of Human Genetics·J CuiG G Giles
Oct 8, 2013·Cancer Epidemiology·Ondrej VencalekMichal Grepl
Mar 23, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Michele L CotéRayjean J Hung
Oct 3, 2014·Journal of Genetic Counseling·Gabrielle T ReidJon D Emery
Jun 19, 1998·American Journal of Human Genetics·P BerthonO Cussenot
Aug 21, 2002·The Journal of Urology·Ola Bratt
Jun 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tuukka MäkinenAnssi Auvinen
Oct 21, 2003·International Journal of Cancer. Journal International Du Cancer·Deborah Watkins BrunerPaul Engstrom
Mar 26, 2004·Cancer·Jennifer L Beebe-DimmerKathleen A Cooney

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Cancer. Journal International Du Cancer
R B HayesR N Hoover
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
O BrattH Olsson
© 2021 Meta ULC. All rights reserved